MALFORMAÇÃO ARTERIOVENOSA CEREBRAL: O RISCO DA EXPOSIÇÃO A METAIS PESADOS
DOI:
https://doi.org/10.56238/revgeov17n2-073Palavras-chave:
Malformação Arteriovenosa Cerebral, Metais Pesados, Ambiente, Fator de RiscoResumo
A malformação arteriovenosa cerebral (MAV) é uma condição rara e potencialmente grave, caracterizada por uma comunicação anormal entre artérias e veias no cérebro. Esta anomalia vascular apresenta alto risco de hemorragia, o que pode levar a morbidade e mortalidade significativas em adultos jovens. Como o diagnóstico e tratamento das MAVs ainda representam desafios clínicos, um dos principais dilemas atualmente é entender como as MAVs se desenvolvem. Nesse sentido, o objetivo desse artigo é demonstrar se o acúmulo de metais pesados pode ser um possível fator de risco ambiental para o surgimento das MAVs.
Downloads
Referências
Abecassis IJ, Xu DS, Batjer HH, Bendok BR. Natural history of brain arteriovenous malformation: a systematic review. Neurosurg Focus. 2014. 37(3): E7.
Berman MF, Sciacca RR, Pile-Spellman J, Stapf C, Connolly ES Jr, Mohr JP, Young WL. The epidemiology of brain arteriovenous malformations. Neurosurgery. 2000;47(2):389-96.
Can A, Gross BA, Du R. The natural history of cerebral arteriovenous malformation. Handb Clin Neurol. 2017. 143: 15-24.
Carvalho C, Moreira PI. Oxidative Stress: A Major Player in Cerebrovascular Alterations Associated to Neurodegenerative Events. Front Physiol. 2018; 9: 806.
Chaddad-Neto F, Joaquim AF, dos Santos MJ, Linhares PW, de Oliveira E. Microsurgical approach of arteriovenous malformations in the central lobule. Arq Neuropsiquiatr. 2008;66(4):872-5.
Chen W, Choi EJ, McDougall CM, Su H. Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets. Transl Stroke Res. 2014. 5(3): 316-29.
Chen Y, Zhu W, Bollen AW, Lawton MT, Barbaro NM, Dowd CF, Hashimoto T, Yang GY, Young WL. Evidence of inflammatory cell involvement in brain arteriovenous malformation. Neurosurgery. 2008. 62(6): 1340-9.
Chen CJ, Ding D, Derdeyn C, Lanzino G, Friedlander RM, Southerland AM, Lawton MT, Sheehan JP. Brain arteriovenous malformation: A review of natural history, pathobiology, and interventions. Neurology. 2020. 95(20): 917-927.
Choi JH, Mast H, Hartmann A, Marshall RS, Pile-Spellman J, Mohr JP, Stapf C. Clinical and morphological determinants of focal neurological deficits in patients with unruptured brain arteriovenous malformation. J Neurol Sci. 2009;287(1-2):126-30.
Chowdhury R, Ramond A, O'Keeffe LM, Shahzad S, Kunutsor SK, Muka T, Gregson J, Willeit P, Warnakula S, Khan H, Chowdhury S, Gobin R, Franco OH, Di Angelantonio E. Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2018 ;362:k3310.
Englot DJ, Young WL, Han SJ, McCulloch CE, Chang EF, Lawton MT. Seizure predictors and control after microsurgical resection of supratentorial arteriovenous malformations in 440 patients. Neurosurgery. 2012;71(3):572-80
Flora SJ, Mittal M, Mehta A. Heavy metal induced oxidative stress & its possible reversal by chelation therapy. Indian J Med Res. 2008;128(4):501-23.
Goldberg J, Raabe A, Bervini D. Natural history of brain arteriovenous malformation: systematic review. J Neurosurg Sci. 2018. 62(4): 437-443
Grasso G. Age-dependent brain AVM characteristics: what is the evidence? Stroke. 2003. 34(11): 2669-70.
Gross BA, Du R. Surgical treatment of high grade dural arteriovenous fistulae. J Clin Neurosci. 2013 Nov;20(11):1527-32.
Grüter BE, Mendelowitsch I, Diepers M, Remonda L, Fandino J, Marbacher S. Combined Endovascular and Microsurgical Treatment of Arteriovenous Malformations in the Hybrid Operating Room. World Neurosurg. 2018;117:e204-e214.
Hashimoto T, Lam T, Boudreau NJ, Bollen AW, Lawton MT, Young WL. Abnormal balance in the angiopoietin-tie2 system in human brain arteriovenous malformations. Circ Res. 2001. 80(2): 111-3.
Hernesniemi JA, Dashti R, Juvela S, Väärt K, Niemelä M, Laakso A. Natural history of brain arteriovenous malformations: a long-term follow-up study of risk of hemorrhage in 238 patients. Neurosurgery. 2008; 63 (5): 823-9.
Hillman J. Population-based analysis of arteriovenous malformation treatment. J Neurosurg. 2001 Oct;95(4):633-7.
Hofmeister C, Stapf C, Hartmann A, Sciacca RR, Mansmann U, terBrugge K, Lasjaunias P, Mohr JP, Mast H, Meisel J. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke. 2000;31(6):1307-10.
Klimo Jr P, Rao G, Brockmeyer D. Pediatric arteriovenous malformation: a 15-year experience with na emphasis on residual and recurrent lesions. Childs Nerv Syst. 2007. 23(1): 31-7.
Komiyama M, Ishiguro T, Kitano S, Sakamoto H, Nakamura H. Serial antenatal sonographic obervation cerebral dural sinus malformation. AJNR Am J Neuroradiol. 2004. 25(8): 1446-8.
Laakso A, Hernesniemi J. Arteriovenous malformations: epidemiology and clinical presentation. Neurosurg Clin N Am. 2012;23(1):1-6.
Lawton MT, Kim H, McCulloch CE, Mikhak B, Young WL. A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery. 2010;66(4):702-13.
Le N, Li Y, Walker G, Nguyen BN, Bornak A, Deo SK, Velazquez OC, Liu ZJ. Arteriovenous Malformations (AVMs): Molecular Pathogenesis, Clinical Features, and Emerging Therapeutic Strategies. Biomolecules. 2025;15(12):1661.
Lee CZ, Xue Z, Zhu Y, Yang GY, Young WL. Matrix metalloproteinase-9 inhibition attenuates vascular endotelial growth fator-induced intracerebral hemorrhage. Stroke. 2007. 38(9): 2563-8.
Lindqvist M, Karlsson B, Guo WY, Kihlström L, Lippitz B, Yamamoto M. Angiographic long-term follow-up data for arteriovenous malformation previously proven to be obliterated after gamma knife radiosergery. Neurosurgery. 2000. 46(4):803-8.
Luschka H. Die Adergeflechte des menschlichen Gehirnes: eine Monographie. Berlim: G. Reimer. 1855. p. 1829-1875.
Mast H, Mohr JP, Osipov A, Pile-Spellman J, Marshall RS, Lazar RM, Stein BM, Young WL. 'Steal' is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations. Stroke. 1995;26(7):1215-20.
Matsoukas S, Bageac DV, DeLeacy R, Berenstein A, Fifi JT. De novo brain AVM following radiotherapy for cerebral cavernous malformation in child: A 15-year clinical course. Neuroradiol J. 2022. 35(4): 533-538.
Mouchtouris N, Jabbour PM, Starke RM, Hasan DM, Zanaty , Theofanis T, Ding D, Tjoumakaris SI, Dumont AS, Ghobrial GM, Kung D, Rosenwasser RH, Chalouhi N. Biology of cerebral arteriovenous malformation with a focus on inflammation. J Cereb Blood Flow Metab. 2015. 35(2): 167-75.
Murphy PA, Kim TN, Huang L, Nielsen CM, Lawton MT, Adams RH, Schaffer CB, Wang RA. Constitutively active Notch4 receptor elicits brain arteriovenous malformation through enlargement of capillary-like vessels. Proc Natl Acad Sci USA. 2014. 111(50): 18007-12.
Osbun JW, Reynolds MR, Barrow DL. Arteriovenous malformation: epidemiology, clinical presentation, and diagnostic evaluation. Handb Clin Neurol. 2017. 143: 25-29.
Patwa J, Flora SJS. Heavy Metal-Induced Cerebral Small Vessel Disease: Insights into Molecular Mechanisms and Possible Reversal Strategies. Int J Mol Sci. 2020; 21(11):3862.
Pawlinkowska L, Tran MN, Achrol AS, McCulloch CE, Há C, Lind DL, Hashimoto T, Zaroff J, Lawton MT, Marchuk DA, Kwok PY, Young WL, UCSF BAVM Study Projetc. olymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke. 2004. 35(10): 2294-300.
Petridis AK, Dibue-Adjei M, Cornelius JF, Suresh MP, Li L, Kamp MA, Abusabha Y, Turowski B, Steiger HJ, May R. Contrast enhancement of vascular walls of intracranial high flow malformations in black blood MRI indicates high inflammatory activity. Chin Neurosurg J. 2018; 4:13.
Porru S, Esplugues A, Llop S, Delgado-Saborit JM. The effects of heavy metal exposure on brain and gut microbiota: A systematic review of animal studies. Environ Pollut. 2024;348:123732.
Prozialeck WC, Edwards JR, Nebert DW, Woods JM, Barchowsky A, Atchison WD. The vascular system as a target of metal toxicity. Toxicol Sci. 2008;102(2):207-18.
Sugyama T, Grasso G, Torregrossa F, Fujimura M. Current Concepts and Perpspectives on Brain Arteriovenous Malformations: A Review of Pathogenesis and Multidisciplinary Treatment. World Neurosurg. 2022. 159: 314-326.
Rutledge C, Cooke DL, Hetts SW, Abla AA. Brain arteriovenous malformations. Handb Clin Neurol. 2021; 176: 171-178.
Stapf C, Khaw AV, Sciacca RR, Hofmeister C, Schumacher HC, Pile-Spellman J, Mast H, Mohr JP, Hartmann A. Effect of age on clinical and morphological characteristics in patients with brain arteriovenous malformation. Stroke. 2003; 34(11):2664-9.
Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ. Heavy metal toxicity and the environment. Exp Suppl. 2012;101:133-64.
Virchow R. Handbuch der speciellen Pathologie und Therapie. 2nd ed. Vol. 6. Enke, 1856.
Winkler EA, Lu AY, Raygor KP, Linzey JR, Jonzzon S, Lien BV, Rutledge WC, Abla AA. Defective vascular signaling and prospective therapeutic targets in brain arteriovenous malformation. Neurochem Int. 2019. 126: 126-138.
Wright R, Järvelin P, Pekonen H, Keränen, Rauramaa T, Frösen J. Histopathology of brain AVMs part II: inflammation in arteriovenous malformation of the brain. Acta Neurochir (Wien). 2020. 162(7): 1741-1747.
